Article: Cpex Pharmaceuticals and Serenity Pharmaceuticals to Partner on Drug Candidate for Urology Indication.

Article: United States: CPEX Pharmaceuticals Inc partners with Serenity Pharmaceuticals on drug candidate for urology indication.
TendersInfo;  August 7, 2008 ;     172 words ......a collaboration with Serenity Pharmaceuticals, a privately held, New-Yo...company, on an intranasal drug candidate for a urology indication...will use Serenity's drug candidate and CPEX's patented...

Article: CPEX Pharmaceuticals and Serenity Pharmaceuticals Announce Collaboration on Drug Candidate for Urology Indication.
Clinical Trials Week;  August 18, 2008 ;     492 words ......privately held Serenity Pharmaceuticals announced...intranasal drug candidate for a urology...Herschkowitz, Serenity Pharmaceuticals' CEO, said...streams. About Serenity Pharmaceuticals Serenity Pharmaceuticals...

Article: CPEX Pharmaceuticals Announces Completion of Phase 2 Trial for Urology Drug by Serenity Pharmaceuticals.(Report)
Clinical Trials Week;  March 9, 2009 ;     685 words ......this urology drug candidate from the...potential of this drug candidate. In addition...continues.o About Serenity Pharmaceuticals Serenity Pharmaceuticals is a privately...product with Serenity Pharmaceuticals and the potential...

Article: Data: Drug candidate MPI-176716 causes ovarian tumor remission.
Biotech Business Week;  February 9, 2004 ;     450 words ......anticancer compound, MPI-176716. The drug candidate is in the final stages of preclinical...in a mouse xenograft model. Myriad's drug candidate was evaluated in comparison to the...by the potential of this promising drug candidate to treat a variety of cancer types...

Article: Myriad Genetics' Cancer Drug Candidate MPI-176716 Causes Ovarian Tumor Remission.
PR Newswire;  January 13, 2004 ;     700+ words ......anti-cancer compound, MPI-176716. The drug candidate is in the final stages of preclinical...in a mouse xenograft model. Myriad's drug candidate was evaluated in comparison to the...by the potential of this promising drug candidate to treat a variety of cancer types...

Article: Pharmaceutical company develops neurodegenerative disease drug candidate.
Drug Week;  November 7, 2003 ;     137 words ......Pharmaceutical Corporation (NYMX) has developed NXD-5150, a new drug candidate for neurodegenerative disease that has successfully completed...in humans in the near term. NXD-5150 is a very promising drug candidate with potential as a treatment for several neurodegenerative...

Article: Formulation Demonstrates Extended Release In Phase I Study.(diabetes drug candidate)(Brief Article)
Diabetes Week;  September 10, 2001 ;     269 words ......of Amylin's type 2 diabetes drug candidate AC2993 (synthetic exendin...Pharmaceuticals has a second diabetes drug candidate in Phase II evaluation for...type 2 diabetes. The third drug candidate, AC3056, is currently in Phase...

Article: Bachem supplies peptide for liver drug candidate.(Jerini AG, contract)(Brief Article)
Chemical Week;  March 31, 2004 ;     155 words ......it has been awarded a contract to manufacture the peptide drug candidate Lcatibant for Jerini (Berlin), a private startup pharma...necessary documentation for the drug's registration. The drug candidate is in phase II clinical trials, and Jerini says it plans...

Article: Canadian biotech adds third drug candidate to its immunosuppressive pipeline.
Immunotherapy Weekly;  December 31, 2003 ;     201 words ......com & NewsRx.net) -- Isotechnika, Inc., (ISA) announced the addition of a third drug candidate to its immunosuppressive drug pipeline. The new drug candidate, TKB662, is designed to address the two major challenges in the field of transplantation...

Article: NEC, Cerep Japan to Collaborate in Search and Analysis of Drug Candidate Compounds
JCNN News Summaries - Japan Corporate News Network;  November 25, 2005 ;     105 words ......form a business alliance to collaborate in searching and analyzing drug candidate compounds. Specifically, by leveraging NEC's virtual screening system for drug candidate compounds and Cerep's compound library and its expertise in pharmacologic...

Article: ORADUR(TM) Technology Milestone: New ORADUR-based Investigational Drug Candidate Commences Phase I Clinical Program.
PR Newswire;  August 2, 2006 ;     700+ words ......clinical trial for a new ORADUR-based opioid drug candidate. This new drug candidate is the second ORADUR-based opioid drug to...company which will be commercializing the drug candidate, if approved, and Pain Therapeutics, Inc...

Article: Boehringer Ingelheim to develop NeuroSearch's drug candidate.(Brief Article)
Nordic Business Report;  February 11, 2002 ;     140 words ......February 2002-Boehringer Ingelheim to develop NeuroSearch's drug candidate (C)1994-2002 M2 COMMUNICATIONS LTD http://www.m2.com The...agreement Boehringer Ingelheim will develop NeuroSearch's NS2330 drug candidate into a drug for the two diseases. It will then also market...

Article: PathoGenesis Corp. Announces Aerosolized Drug Candidate License.
PR Newswire;  October 1, 1998 ;     606 words ......market an antibiotic for inhalation. The drug candidate has been named PA-1806. PA-1806 demonstrates...class of antibiotics. A patent on the drug candidate (originally BMS-180680) was issued...the U.S. and has a second aerosolized drug candidate, PA-1420, in preclinical development...

Article: NPS updates the status of 2 drug-candidate studies
Deseret News (Salt Lake City);  October 8, 2003 ;     166 words ......Tuesday it has completed part of its third-phase trial for its Preos osteoporosis drug candidate and has under way a proof-of-concept study for drug candidate teduglutide. NPS said it has completed dosing of patients participating in its 18-mon...